FMR LLC - AMYLYX PHARMACEUTICALS INC ownership

AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 175 filers reported holding AMYLYX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.

Quarter-by-quarter ownership
FMR LLC ownership history of AMYLYX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,032,340
-17.1%
438,686
-2.3%
0.00%0.0%
Q2 2023$9,684,542
+2182.7%
448,982
+3005.0%
0.00%
Q1 2023$424,256
+47.1%
14,460
+85.3%
0.00%
Q4 2022$288,358
+3104.0%
7,804
+2222.6%
0.00%
Q3 2022$9,000
-99.6%
336
-99.7%
0.00%
Q2 2022$2,358,000
+108.3%
122,443
+38.9%
0.00%
Q1 2022$1,132,00088,1250.00%
Other shareholders
AMYLYX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 6,088,333$224,963,9046.32%
Alpha Wave Global, LP 821,220$30,344,0795.54%
Ghost Tree Capital, LLC 350,000$12,933,0005.52%
Boxer Capital, LLC 2,084,000$77,003,8004.06%
Altium Capital Management LP 140,000$5,173,0002.63%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,693,000$99,506,3502.06%
Iron Triangle Partners LP 240,240$8,876,8681.59%
EMERALD MUTUAL FUND ADVISERS TRUST 655,015$24,202,8041.50%
EMERALD ADVISERS, LLC 836,909$30,923,7881.49%
GREAT POINT PARTNERS LLC 190,000$7,020,5001.38%
View complete list of AMYLYX PHARMACEUTICALS INC shareholders